Summary of results A: Pain‐free and headache relief in placebo controlled studies | ||||||
Studies |
Attacks treated |
Treatment (%) |
Placebo (%) |
Relative risk (95% CI) |
NNT (95% CI) |
|
Pain‐free at 2 hours | ||||||
Sumatriptan 4 mg | 2 | 664 | 49 | 9 | 4.8 (3.2 to 7.2) | 2.5 (2.2 to 3.0) |
Sumatriptan 6 mg | 13 | 2522 | 59 | 15 | 3.9 (3.3 to 4.5) | 2.3 (2.1 to 2.4) |
Sumatriptan 6 mg (+ 6 mg) | 3 | 388 | 50 | 11 | 4.6 (2.9 to 7.4) | 2.6 (2.1 to 3.2) |
Pain‐free at 1 hour | ||||||
Sumatriptan 4 mg | 2 | 664 | 33 | 6 | 4.7 (2.8 to 7.7) | 3.8 (3.2 to 4.8) |
Sumatriptan 6 mg | 16 | 3592 | 41 | 7 | 5.6 (4.6 to 6.8) | 2.9 (2.7 to 3.2) |
Sumatriptan 8 mg | 2 | 308 | 46 | 6 | 7.1 (3.8 to 13) | 2.5 (2.0 to 3.2) |
Headache relief at 1 hour | ||||||
Sumatriptan 4 mg | 2 | 664 | 66 | 25 | 2.6 (2.0 to 3.2) | 2.5 (2.1 to 3.0) |
Sumatriptan 6 mg | 24 | 5177 | 71 | 26 | 2.7 (2.5 to 2.9) | 2.2 (2.1 to 2.4) |
Sumatriptan 8 mg | 3 | 361 | 80 | 23 | 3.6 (2.7 to 4.7) | 1.7 (1.5 to 2.0) |
Headache relief at 2 hours | ||||||
Sumatriptan 4 mg | 2 | 664 | 70 | 22 | 3.1 (2.4 to 4.0) | 2.1 (1.8 to 2.5) |
Sumatriptan 6 mg | 14 | 2738 | 79 | 31 | 2.5 (2.3 to 2.7) | 2.1 (2.0 to 2.2) |
Sumatriptan 6 mg (+6 mg) | 6 | 1728 | 79 | 32 | 2.4 (2.1 to 2.7) | 2.1 (1.9 to 2.3) |
Sustained pain‐free during the 24 hours postdose | ||||||
Sumatriptan 6 mg | 5 | 1336 | 31 | 15 | 2.2 (1.8 to 2.8) | 6.1 (4.8 to 8.2) |